Krishna S. Naruganahalli

Therapeutic potential of Aurora kinase inhibitors in cancer.

Krishna S. Naruganahalli, Manikandan Lakshmanan, Sunanda G. Dastidar et al. · PubMed · 2006 · 23 citations

Cell Cycle, Aurora Kinase Inhibitors, Tumor Biology +16

Role of peripheral 5-HT1A receptors in detrusor over activity associated with partial bladder outlet obstruction in female rats

Shivani Mittra, Shivani Malhotra, Krishna S. Naruganahalli et al. · European Journal of Pharmacology · 2007 · 19 citations

Urological Research, Urology, Voiding Dysfunction +9

Ranbezolid, a novel oxazolidinone antibacterial: In vivo characterisation of monoamine oxidase inhibitory potential in conscious rats

Krishna S. Naruganahalli, Raj Kumar Shirumalla, Vimal Bansal et al. · European Journal of Pharmacology · 2006 · 14 citations

Psychoactive Drug, Health Sciences, Pharmacological Study +9

RBx 6198: A novel α1-adrenoceptor antagonist for the treatment of benign prostatic hyperplasia

Kamna Nanda, Krishna S. Naruganahalli, Suman Gupta et al. · European Journal of Pharmacology · 2009 · 11 citations

Molecular Pharmacology, Urology, Rbx 6198 +6

RBx 7796: A novel inhibitor of 5-lipoxygenase

Rajkumar Shirumalla, Krishna S. Naruganahalli, Sunanda G. Dastidar et al. · Inflammation Research · 2006 · 11 citations

Molecular Pharmacology, Rbx 7796, Biochemistry +6